human
metapneumoviru
discov
recent
respiratori
viru
implic
upper
lower
respiratori
tract
infect
children
clinic
symptom
human
metapneumoviru
similar
produc
respiratori
syncyti
viru
rang
mild
sever
diseas
bronchiol
pneumonia
aim
present
studi
describ
preval
human
metapneumoviru
common
respiratori
virus
among
admit
hospit
infant
januari
june
nasopharyng
aspir
collect
hospit
children
younger
month
order
studi
respiratori
virus
human
metapneumoviru
detect
perform
cell
cultur
two
rtpcr
target
polymeras
fusion
gene
latter
gene
use
phylogenet
analysi
children
least
one
viral
pathogen
identifi
virus
detect
frequent
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
result
obtain
studi
show
human
metapneumoviru
one
import
virus
among
children
less
month
children
infect
human
metapneumoviru
significantli
older
infect
respiratori
syncyti
viru
human
metapneumoviru
associ
frequent
pneumonia
wherea
respiratori
syncyti
viru
detect
patient
bronchiol
clear
epidemiolog
success
pattern
small
overlap
among
virus
detect
frequent
human
metapneumoviru
sampl
cluster
within
sublineag
human
metapneumoviru
discov
recent
respiratori
viru
implic
upper
lower
respiratori
tract
infect
rang
mild
sever
diseas
age
group
van
den
hoogen
et
al
sinc
report
europ
asia
australia
south
africa
america
peret
et
al
bastien
et
al
jpma
et
al
rao
et
al
sloot
et
al
brook
et
al
suggest
worldwid
distribut
seropreval
studi
shown
viru
present
among
human
five
decad
van
den
hoogen
et
al
hamelin
et
al
human
metapneumoviru
discov
previous
due
difficulti
grow
tradit
cell
cultur
although
slow
growth
rhesu
monkey
kidney
cell
line
deffrasn
et
al
although
monoclon
antibodi
mab
develop
landri
et
al
percival
et
al
avail
commerci
direct
antigen
detect
nasopharyng
aspir
npa
molecular
assay
remain
main
approach
avail
current
human
metapneumoviru
identif
human
metapneumoviru
negativestrand
rna
genom
approxim
kb
encapsid
helicoid
nucleocapsid
cover
lipid
bilay
van
den
hoogen
et
al
biacchesi
et
al
classifi
pneumoviru
subfamili
paramyxoviru
famili
also
contain
respiratori
syncyti
viru
metapneumoviru
genu
current
two
main
genotyp
b
subtyp
identifi
molecular
method
biacchesi
et
al
clinic
symptom
human
metapneumoviru
similar
caus
respiratori
syncyti
viru
rang
wheez
cough
fever
bronchiol
even
pneumonia
wolf
et
al
although
studi
detect
human
metapneumoviru
age
group
human
metapneumoviru
infect
could
sever
children
elderli
immunocompromis
patient
pelleti
et
al
bastien
et
al
cane
et
al
falsey
et
al
howev
sever
epidemiolog
clinic
featur
yet
establish
firmli
aim
present
studi
describ
role
human
metapneumoviru
common
respiratori
virus
includ
influenza
viru
b
c
parainfluenza
virus
adenovirus
respiratori
syncyti
viru
b
rhinoviru
coronaviru
enteroviru
bronchiol
bronchopneumonia
pathogen
among
hospit
children
younger
year
take
account
age
group
respiratori
virus
main
etiolog
agent
lower
respiratori
tract
infect
shay
et
al
smyth
openshaw
bush
thomson
addit
human
metapneumoviru
posit
sampl
compar
phylogenet
analysi
fusion
f
gene
sequenc
carri
studi
potenti
circul
distinct
human
metapneumoviru
genotyp
among
patient
includ
present
studi
fall
within
framework
studi
preval
clinic
epidemiolog
featur
associ
human
metapneumoviru
infect
among
infant
adult
popul
award
fondo
de
investigacion
sanitaria
fi
spain
januari
june
children
younger
month
hospit
children
hospit
hospit
sant
joan
de
barcelona
spain
bronchiol
bronchopneumonia
studi
prospect
within
first
hr
admiss
nasopharyng
aspir
collect
deliv
laboratori
microbiolog
hospit
barcelona
process
studi
respiratori
virus
questionnair
clinic
epidemiolog
featur
also
complet
initi
consult
routin
bacteriolog
test
blood
urin
perform
febril
infant
toxic
manifest
defin
clinic
appear
consist
sepsi
syndrom
baraff
et
al
respiratori
sampl
obtain
accord
clinic
indic
decis
attend
physician
bronchiol
defin
acut
infect
lower
airway
character
increas
respiratori
effort
tachypnea
expiratori
wheez
andor
crackl
associ
common
viral
infect
symptom
rhinorrhea
cough
infant
younger
year
presenc
lower
respiratori
infect
wheez
andor
crackl
focal
infiltr
chest
xray
consid
bronchopneumonia
exclus
criteria
underli
medic
condit
cystic
fibrosi
metabol
diseas
neurolog
diseas
patient
two
previou
episod
wheez
without
presenc
radiolog
infiltr
criteria
pediatr
intens
care
unit
picu
admiss
acut
respiratori
failur
hemoglobin
satur
fraction
inspir
oxygen
fio
supplement
common
episod
apnea
sepsi
accord
intern
consensu
confer
pediatr
sepsi
goldstein
et
al
inform
consent
obtain
patient
parent
ethic
committe
hospit
hospit
sant
joan
de
approv
studi
protocol
specimen
immunofluoresc
assay
ifa
suspend
pb
phosphat
buffer
salin
necessari
spot
onto
slide
airdri
fix
cold
aceton
stain
pool
fluoresceinconjug
antibodi
influenza
viru
influenza
viru
b
human
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
respiratori
panel
viral
screen
identif
kit
light
diagnost
chemicon
intern
temecula
usa
simultan
specimen
inocul
mdck
madin
darbi
canin
kidney
human
caucasian
larynx
carcinoma
squamou
cell
rhesu
monkey
kidney
epitheli
cell
cell
line
vircel
granada
spain
isol
virus
mention
human
metapneumoviru
mdck
tube
cultur
incub
respect
maintain
growth
essenti
medium
emem
ebss
mm
glutamin
nonessenti
amino
acid
neaa
ad
ml
mgml
trypsinedta
optim
growth
influenza
virus
human
metapneumoviru
cell
line
maintain
medium
plu
fetal
bovin
serum
incub
cell
cultur
examin
twice
weekli
develop
cytopath
effect
posit
cultur
harvest
stain
convent
viru
identif
ifa
ifa
neg
case
rtpcr
revers
transcriptionpolymeras
chain
reaction
common
respiratori
virus
human
metapneumoviru
undertaken
upon
sampl
collect
aliquot
fresh
specimen
collect
use
rtpcr
analysi
nucleic
acid
either
dnarna
virus
present
nasopharyng
secret
infect
cell
cultur
extract
ml
specimen
use
nuclisens
easymag
rm
boxtel
netherland
accord
manufactur
instruct
lysi
buffer
includ
molecul
clonedamplifi
product
use
intern
control
reaction
tube
order
exclud
fals
neg
result
due
nonspecif
inhibitor
extract
failur
two
independ
multiplex
nest
rtpcr
assay
abl
detect
copi
viral
genom
carri
use
techniqu
describ
previous
coira
et
al
coira
et
al
one
rtpcr
assay
detect
influenza
viru
influenza
viru
b
influenza
viru
c
respiratori
syncyti
viru
respiratori
syncyti
viru
b
adenoviru
anoth
rtpcr
assay
examin
human
parainfluenza
viru
human
coronaviru
human
coronaviru
gener
detect
enteroviru
rhinoviru
order
detect
human
metapneumoviru
extract
rna
use
templat
cdna
synthesi
random
primer
accord
manufactur
instruct
first
strand
cdna
synthesi
kit
roch
diagnost
mannheim
germani
amplif
reaction
carri
use
specif
primer
amplifi
conserv
fragment
bp
polymeras
gene
l
lf
cat
gcc
cac
tat
aaa
agg
tca
g
lr
cac
ccc
agt
ctt
tct
tga
aa
describ
elsewher
pcr
condit
compris
cycl
min
denaturalizaton
sec
anneal
min
extens
final
extens
min
detect
human
metapneumoviru
type
b
addit
wide
use
primer
l
gene
hybrid
type
b
sarasini
et
al
second
nest
pcr
test
use
fusion
gene
f
primer
perform
first
round
pcr
use
follow
primer
ttc
gtt
cta
gga
gca
fr
gtc
ttc
ctg
tcg
taa
ctt
tg
second
round
use
inner
forward
primer
ff
atg
cca
aca
tct
gca
gga
c
revers
primer
first
step
obtain
final
product
pb
amplifi
product
analyz
electrophoresi
agaros
gel
stain
ethidium
bromid
fusion
gene
primer
either
select
publish
protocol
design
origin
base
sequenc
data
canadian
strain
avail
genbank
nation
center
biotechnolog
inform
genbank
access
biacchesi
et
al
human
metapneumoviru
posit
control
rna
human
metapneumoviru
subtyp
accord
strain
canada
use
pcr
test
set
rtpcr
reaction
includ
posit
control
extract
amplif
handl
obtain
viral
lysat
avail
neg
control
viral
transport
medium
contain
nucleic
acid
posit
result
confirm
two
sequenti
assay
addit
second
nest
pcr
target
fragment
f
gene
also
use
phylogenet
analysi
confirm
previou
l
gene
posit
result
identifi
probabl
human
metapneumoviru
type
b
bouscambertduchamp
et
al
banerje
et
al
cdna
synthes
previous
use
templat
first
f
gene
pcr
amplif
reaction
mix
contain
primer
termocycl
condit
cycl
min
denatur
min
anneal
min
extens
final
extens
step
min
second
round
pcr
use
inner
primer
ff
revers
primer
use
pcr
anneal
reaction
perform
instead
condit
reaction
volum
ident
appli
first
round
pcr
reaction
produc
proper
band
purifi
qiaquick
gel
extract
kit
qiagen
izasa
spain
sequenc
bigdy
termin
appli
biosystem
foster
citi
usa
abi
prism
dna
analyz
appli
biosystem
foster
citi
usa
sequenc
align
differ
human
metapneumoviru
subtyp
strain
canada
netherland
japan
access
no
bastien
et
al
galiano
et
al
huck
et
al
avian
metapneumoviru
c
sequenc
access
use
outgroup
govindarajan
et
al
nucleotid
sequenc
align
gener
use
clustalw
algorithm
mega
softwar
kumar
et
al
total
length
sequenc
nucleotid
phylogenet
molecular
analys
conduct
use
mega
version
phylogenet
tree
construct
phylip
program
packag
version
felsenstein
depart
genet
univers
washington
seattl
wa
use
neighborjoin
method
suppli
treeview
program
preval
human
metapneumoviru
calcul
number
children
posit
pcr
human
metapneumoviru
divid
number
children
age
group
admit
period
hospit
lower
respiratori
tract
infect
quantit
variabl
describ
mean
ae
standard
deviat
signific
differ
respiratori
syncyti
viru
human
metapneumoviru
group
analyz
use
mannwhitney
utest
qualit
variabl
report
frequenc
percentag
comparison
proport
determin
w
fisher
exact
test
probabl
valu
p
consid
signific
analysi
perform
use
graphpad
statist
program
graphpad
softwar
inc
san
diego
ca
januari
june
children
younger
month
hospit
lower
respiratori
tract
infect
nasopharyng
aspir
respiratori
virus
detect
includ
prospect
median
age
patient
ae
month
rang
day
month
includ
male
femal
clinic
diagnos
time
admiss
bronchiol
bronchopneumonia
respect
etiolog
diagnosi
children
least
one
viral
pathogen
identifi
infect
one
virus
investig
wherea
coinfect
least
two
virus
total
virus
identifi
patient
remain
without
etiolog
diagnosi
frequent
viru
detect
respiratori
syncyti
viru
follow
human
metapneumoviru
rhinoviru
fig
viral
coinfect
observ
case
adenoviru
rhinoviru
common
virus
identifi
one
patient
bronchopneumonia
tripl
infect
detect
respiratori
syncyti
viru
adenoviru
rhinoviru
blood
urin
cultur
obtain
patient
criteria
toxic
manifest
none
specimen
blood
urin
grew
pathogen
three
bronchial
aspir
one
bronchoalveolar
lavag
collect
haemophilu
influenza
streptococcu
pneumonia
recov
bronchial
aspir
bronchoalveolar
lavag
respect
diagnosi
bronchiol
significantli
frequent
respiratori
syncyti
viru
singleinfect
children
p
wherea
human
metapneumoviru
infect
significantli
common
among
infant
pneumonia
p
tabl
human
metapneumoviru
infect
children
significantli
older
mean
age
ae
month
infect
respiratori
syncyti
viru
mean
age
ae
month
p
tabl
ii
iii
thirteen
patient
requir
hospit
pediatr
intens
care
unit
picu
first
diagnos
bronchiol
two
bronchopneumonia
eleven
patient
admit
picu
etiolog
diagnosi
respiratori
syncyti
viru
rhinoviru
human
metapneumoviru
human
metapneumoviru
rhinoviru
respiratori
syncyti
viru
adenoviru
h
influenza
pneumonia
respiratori
syncyti
viru
durat
hospit
day
mean
ae
although
differ
statist
signific
patient
dual
viral
infect
requir
day
recov
ae
day
singl
infect
ae
day
overal
human
metapneumoviru
case
detect
rtpcr
could
also
recov
cell
line
sampl
j
med
virol
doi
human
metapneumoviru
posit
rtpcr
target
l
gene
also
confirm
rtpcr
base
f
gene
sequenc
f
amplicon
human
metapneumoviru
strain
identifi
npa
subsequ
phylogenet
analysi
show
type
human
metapneumoviru
circul
among
patient
includ
studi
period
fig
human
metapneumoviru
sampl
test
found
cluster
share
nucleotid
ident
slightli
higher
amino
acid
similar
notabl
sequenc
examin
leav
patient
similar
increas
phylogenet
tree
sequenc
seem
form
differ
cluster
within
subtyp
fig
present
studi
base
first
half
year
thu
difficult
establish
distribut
virus
detect
followup
nonetheless
month
differ
distribut
pattern
among
virus
detect
frequent
fig
acut
respiratori
tract
infect
import
caus
morbid
mortal
children
well
known
high
percentag
infect
caus
respiratori
virus
william
et
al
jen
et
al
meissner
pierang
et
al
date
respiratori
syncyti
viru
import
trigger
acut
respiratori
tract
infect
although
role
respiratori
virus
rhinoviru
human
metapneumoviru
van
den
hoogen
et
al
human
van
der
hoek
et
al
human
woo
et
al
human
bocaviru
alland
et
al
gain
attent
increasingli
present
report
respiratori
virus
involv
either
bronchiol
bronchopneumonia
patient
admit
hospit
despit
fact
human
metapneumoviru
respiratori
syncyti
viru
common
pathogen
children
patient
infect
human
metapneumoviru
significantli
older
respiratori
syncyti
virusinfect
patient
find
report
elsewher
william
et
al
wolf
et
al
chung
et
al
despit
fact
limit
rang
age
popul
select
similar
result
previou
studi
found
wright
et
al
chung
et
al
weigl
et
al
suggest
first
year
life
respiratori
virus
import
pathogen
caus
sever
respiratori
tract
infect
result
hospit
admiss
sever
studi
demonstr
human
metapneumoviru
like
associ
bronchiol
earli
childhood
xepapadaki
et
al
garciagarcia
et
al
carmo
debur
et
al
howev
investig
includ
present
studi
found
human
metapneumoviru
associ
frequent
bronchopneumonia
compar
human
metapneumovirusbronchiol
case
choi
et
al
brook
et
al
variabl
result
may
reflect
human
metapneumoviru
exclus
bronchiol
pathogen
also
caus
bronchopneumonia
among
infant
probabl
indic
human
metapneumoviru
caus
spectrum
lower
respiratori
tract
ill
tendenc
toward
sever
end
name
pneumonia
studi
sampl
human
metapneumoviru
present
patient
caus
either
bronchiol
broncopneumonia
percentag
second
respiratori
syncyti
viru
surpass
rhinoviru
compar
studi
higher
rate
human
metapneumoviru
infect
obtain
consid
respons
normal
hospit
children
suffer
acut
respiratori
tract
infect
jpma
et
al
deffrasn
et
al
howev
rate
reflect
data
first
half
year
correspond
peak
infect
period
thu
increas
proport
human
metapneumoviru
case
probabl
led
overestim
real
preval
dual
viral
infect
frequent
childhood
mainli
infant
date
associ
increas
sever
ill
william
et
al
wolf
et
al
van
woensel
et
al
contrast
studi
found
increas
sever
diseas
human
metapneumoviru
respiratori
syncyti
viru
dual
infect
greensil
et
al
sempl
et
al
present
studi
show
viral
coinfect
although
human
metapneumoviru
plu
respiratori
syncyti
viru
case
detect
coinfect
patient
requir
longer
recoveri
thirteen
patient
requir
hospit
pediatr
intens
care
unit
respiratori
syncyti
viru
rhinoviru
main
respiratori
virus
involv
either
singl
pathogen
coinfect
requir
day
pediatr
intens
care
unit
interestingli
one
rhinovirusinfect
patient
spent
day
pediatr
intens
care
unit
although
studi
need
evalu
role
sever
ill
respiratori
syncyti
viru
studi
wide
case
involv
sever
acut
respiratori
infect
howev
shown
rhinoviru
also
lifethreaten
viru
among
children
lower
respiratori
infect
guittet
et
al
calvo
et
al
current
four
distinct
major
human
metapneumoviru
phylogenet
lineag
describ
studi
period
human
metapneumoviru
case
detect
belong
type
maertzdorf
et
al
highlight
strain
particularli
sublineag
could
detect
wide
use
pair
primer
publish
van
den
hoogen
et
al
nonetheless
sampl
test
either
l
f
gene
rtpcr
consid
followup
human
metapneumoviru
subtyp
circul
among
patient
includ
studi
interestingli
studi
undertaken
year
base
children
upper
respiratori
infect
attend
differ
primari
care
center
catalonia
observ
cocircul
lineag
among
human
metapneumoviru
identifi
unpublish
data
recent
huck
et
al
describ
novel
human
metapneumoviru
sublineag
within
group
divid
present
report
sequenc
within
group
share
nucleotid
ident
patient
exclud
ident
sequenc
reach
suggest
patient
may
belong
anoth
cluster
one
limit
studi
followup
done
short
period
time
even
though
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
case
occur
defin
success
small
overlap
virus
report
studi
choi
et
al
pierang
et
al
studi
would
valuabl
investig
season
pattern
chang
take
account
either
entir
year
wider
age
group
thu
establish
true
pattern
respiratori
virus
overal
result
obtain
studi
show
human
metapneumoviru
one
import
virus
among
hospit
children
less
month
therefor
import
caus
sever
lower
respiratori
tract
infect
age
group
children
infect
human
metapneumoviru
significantli
older
mean
month
infect
respiratori
syncyti
viru
mean
month
human
metapneumoviru
associ
frequent
pneumonia
wherea
respiratori
syncyti
viru
detect
bronchiol
case
human
metapneumoviru
associ
spectrum
lower
respiratori
tract
ill
greater
predominac
popul
pneumonia
although
respiratori
syncyti
viru
human
metapneumoviru
circul
mainli
winter
season
clear
success
small
overlap
virus
human
metapneumoviru
sequenc
cluster
within
sublineag
